Simplex Trading
TNGX icon

Simplex Trading’s Tango Therapeutics TNGX Stock Holding History

Simplex Trading’s Portfolio TNGX Stock Details TNGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$16.7K Buy
800
+400
+100% +$5.57K ﹤0.01% 6906
2025
Q4 		$3.54K Sell
400
-2,600
-87% -$22.4K ﹤0.01% 7608
2025
Q3 		$25K Buy
+3,000
New +$20.3K ﹤0.01% 7154
2024
Q4 		– Sell
-700
Closed -$5K – 9639
2024
Q3 		$5K Buy
+700
New +$6.68K ﹤0.01% 7650

Other funds holding TNGX

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
BCM
Boxer Capital Management San Diego, California $762M AUM 1,125.36% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
TGI
TRV GP IV Boston, Massachusetts $267M AUM 965.83% 1-Year Est. Return

Simplex Trading's TNGX Position: Q1 2026 in Review

Simplex Trading opened a new position in Tango Therapeutics (TNGX) in Q1 2026: 1,056 shares worth $22.1K. The stake represents ﹤0.01% of the portfolio and ranks #6697 among its holdings. This is a return to the name: Simplex Trading previously reported a position in TNGX as recently as Q2 2025.

Simplex Trading first reported a position in TNGX in Q4 2023 and has held it in 4 quarters since. The position peaked at $255K in Q2 2025. 194 funds tracked by Wall St. Rank hold TNGX as of Q1 2026.

  • Simplex Trading held 1,056 shares of Tango Therapeutics worth $22.1K as of Q1 2026.
  • Tango Therapeutics was a new Simplex Trading position in Q1 2026.
  • Tango Therapeutics made up ﹤0.01% of Simplex Trading's portfolio in Q1 2026, its #6697 holding.
  • Simplex Trading first reported a position in Tango Therapeutics in Q4 2023 and has held it in 4 quarters since.
  • Simplex Trading's Tango Therapeutics position peaked at $255K in Q2 2025.
  • 194 funds tracked by Wall St. Rank held Tango Therapeutics as of Q1 2026.

Based on Simplex Trading's 13F filing for Q1 2026, filed 14 May 2026.